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ABSTRACT
Background: Cerebral venous sinus thrombosis (CVST) is an uncommon neurological 
deficit. It shows a wide range of clinical manifestations that may mimic many other 
neurological disorders and lead to misdiagnosis. Imaging plays a key role in the 
diagnosis. 
Objective: To evaluate the clinical characteristics and patterns of neuroimaging findings 
in patients with radiologically confirmed CVST.
Design: A retrospective study.
Setting: Kenyatta National Hospital, a tertiary referral and teaching hospital in Nairobi 
Kenya.
Subjects:  Fifty one patients treated for CVST in the hospital were studied.
Results: Fifty one patients with CVST were seen over the last five years. The median age 
of 30 years. The most common age group affected was 25-34 years. Females were more 
affected (n=38, 74.5%) than males (n=13, 25.5%). The most common presenting clinical 
features documented were headache, seizures and neurological deficits. Aetiological 
factors commonly seen included infection (n=20, 39.2%), pregnancy and puerperium 
(n=7, 13.7%) and oral contraceptive use (n=2, 3.9%).  The most common NECT scan 
findings were hyperdense sinus and parenchymalchanges. MRI showed loss of signal 
void in the sinus, gyral swelling and parenchymal signal change.
Conclusion: CVST is most commonly seen in young adult females   due to infection, 
pregnancy, puerperium and oral contraceptive use. The most common clinical finding in 
patients with CVST is headache, followed by seizures, neck pain, neurological deficits 
and visual disturbance. Infective cause is much more common in our population and 
other developed countries compared to the developed world. 
INTRODUCTION
Cerebral venous sinus thrombosis is a relatively 
uncommon but serious neurologic disorder that is 
potentially reversible with prompt diagnosis and 
appropriate medical care (1).  Because the possible 
causal factors and clinical manifestations of this 
disorder are many and varied, imaging plays a 
primary role in the diagnosis. Non-enhanced 
computed tomography(NE CT) and enhanced CT, 
Magnetic resonance  imaging (MRI) ,  TOF (time of 
flight) MR venography, and contrast enhanced MR 
venography and CT venography are particularly 
useful techniques for detecting cerebral venous 
and brain parenchymal changes that are related to 
thrombosis.
 The clinical presentation is highly variable. 
Most patients present with headache, seizures, focal 
neurologic deficit and visual disturbances.
 There are about 100 known causes of CVST. 
Investigators of the International study for Cerebral 
Venous Sinus Thrombosis (ICVST)have shown 
that 44% of cases had more than one predisposing 
factor. Most common causes include deficiencies in 
antithrombin III, protein C and protein S, presence of 
factor V Leiden, oral contraceptive use, pregnancy and 
puerperium and CNS and head and neck infections 
and tumors. In about 15-25 cases no cause is found.
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It is now known that MRI and MRV are the best 
imaging methods for demonstrating CVST. However 
because of the non –specific presentation most 
patients will have NECT as the first imaging study 
for evaluation of their neurological presentation. 
However it is important to appreciate that NECT is 
an unreliable tool for imaging patients with CVST. 
Even addition of contrast still misses 30% of cases. The 
time of flight (TOF) MRV studies show flow related 
imaging artifacts. Contrast enhanced MR venography 
gives superior depiction of the venous sinuses and 
shows small cortical veins to advantage.
 CT venography is a rapid and readily available 
technique that depicts venous anatomy accurately. 
Recent comparative studies with MRV have shown 
that it has equivalent accuracy for detection of venous 
thrombosis with highly detailed depiction of cerebral 
venous anatomy superior to TOF MRV. The drawbacks 
of CTV include difficulty in reconstruction of MIP 
images with subtraction of bone and use of ionising 
radiation. CT venography and MR venography are 
the most reliable imaging tools , however they are 
uncommonly used.
MATERIALS AND METHODS
A five year retrospective cross sectional descriptive 
study was conducted at Kenyatta National Hospital. 
Clinical and imaging records of patients treated 
and followed up for CVST from September 2006 to 
September 2011 were obtained.
 Imaging reports were obtained from radiology 
records and reviewed to identify file numbers. The 
files then were retrieved and clinical information 
obtained. Each patient’s hospital number, age, sex 
and clinical feature were recorded. Review of all 
available CT and MRI scans for the last five years 
was done and where cases were identified the files 
were obtained and reviewed.
 Screening results for pre-thrombotic states and 
HIV status where available were recorded.
 The X-Ray number was obtained from the 
radiology reportor from the file and then used 
to retrieve the imaging study for patients whose 
examination was done in KNH. For patients done 
elsewhere and for patients done in KNH but imaging 
study was not available credible report was obtained 
from the file. Cases where the imaging study or 
credible report was not available were excluded. 
Other files were obtained from the main records 
department using the International Classification of 
Diseases (ICD 10) for CVST. A total of 67 cases were 
identified but 16 were rejected due to missing imaging 
study or clinical records.
RESULTS
51 patients with CVST were seen with age range nine 
months to 80 years. Median age was 30 years. The most 
common age group affected was 25-34 years.  Most 
cases of CVST occurred in patients’ ages between 17 
to 34 years (59.6%). This is corresponds to data from 
other studies that have shown the commonest age 
group affected as 20-40 year old especially in females. 
There were only 5 (10.6%) patients in the paediatric 
age group (0 to 16 years) and this included a single 
infant aged nine months. There were no neonates. 
Females were more affected (n=38, 74.5%) than males 
(n=13, 25.5%). The proportion of female patients in 
the study was statistically significantly higher than 
that of male patients (difference = 49%, 95% CI 32.1% 
to 65.9%, p < 0.001).
Figure 1
Age distribution of patients withCVST.
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Table 1
Distribution of patients age according to gender
Male Female Total P value (Fisher's test)
Age group
0-16 years 1(20) 4(80) 5(100) 0.082
17-24 years 2(22.22) 7(77.78) 9(100)
25-39 years 5(29.41) 12(70.59) 17(100)
35-49 years 0(0) 11(100) 11(100)
50 years and above 3(60) 2(40) 5(100)
Figure 2
Clinical presentation of CVST patients at KNH
Clinical presentation: As shown in Figure 2, CVST most 
commonly presented either as a headache (60.78%) 
or seizures (23.53%). The next most common clinical 
presentation was neurological deficit affecting a total 
of 14 patients. Among these patients seven (13.73%) 
had hemiplegia, two (3.92 %) had hemiparesis and 
5 (9.8%) had focal neurological deficits.  No patients 
presented with speech defects. Vomiting, visual 
disturbance, altered consciousness not including 
coma, thunderclap headache each affected less than 
10% of patients. Twelve (23.53%) patients presented 
with other complaints, most commonly neck pains (n 
= 5, 9.8%). The other presentations affecting a single 
patient each were confusion, syncope, papilloedema, 
loss of memory, abdominal pain and senile dementia.
 Aetiological factors commonly recorded included 
infection (n=20,39.2%), pregnancy and puerperium 
(n=7,13.7%), oral contraceptive use ( n=2,3.9%) and 
associated DVT (n=2, 3.9%).Of the infective causes 
meningitis (13.73%) was the most common condition 
followed by sinusitis (7.84%). Other conditions 
included mastoiditis 2(3.96%), metastasis 2(3.96%), 
encephalitis 1 (1.96%) and trauma 1(1.96%).This is at 
variance with findings in other studies where infective 
causes have been shown to account for only 8.2%. 
 Out of the 51 patients in the study the HIV status 
of 16 (31.37 %) patients was known while for 35 (68.63 
%) no screening results could be obtained. For the 16 
patients for whom HIV status was known 11 tested 
negative while five were HIV positive. Therefore 
the actual prevalence of HIV among these patients 
could not be obtained. However the percentage of 
patients with HIV who also had co-morbid illness 
was significantly higher (80%) than that of patients 
without HIV(  18.18% ) . This then may increase the 
risk of CVST in patients infected with HIV.
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Table 2
CT findings among patients with CVST at KNH
Number (%)
Parenchymal changes
   Parietal 19 (37.25)
   Frontal 12 (23.53)
   Occipital 5 (9.8)
   Temporal lobe 3 (5.88)
   Parasagittal 2 (3.92)
   Thalamus 2 (3.92)
   Pons 1 (1.96)
   Brain oedema 12(23,53)
Presence of haemorrhage 6 (11.76)
CET Findings
   Empty delta sign 16 (31.37)
   Non-enhancing sinus 3 (5.88)
   Both empty delta and non-enhancing sinus 8 (15.69)
   Any documented CET finding 27 (52.94)
CT Scan Findings: Brain CT was done in 39 out of the 
51 patients in the study with 23 (45.10%) patients 
showing parenchymal changes.  As shown in Table 
2 the most common sites of parenchymal changes 
were the parietal (37.25%) and temporal (23.53%) 
areas. NECT signs of thrombosis were observed in 
23 patients, 19 (37.25%) patients had hyperdense 
sinus and 4 (7.84%) had both cord signs and 
hyperdensesinus. Nineteen patients had parenchymal 
changes in the hemispheres with the left side being 
affected more commonly (n =15) than the right side 
(n = 4). Out of 27 (52.94%) patients with documented 
CET finding, 16 had empty delta sign and 3 had non 
enhancing sinus, and 8 patients had both signs. The 
most commonly affected sinus was the superior 
sagittal sinus followed by the transverse sinuses.
MRI Findings: 19 patients had MRI done.  MRI sinus 
signal was predominantly hyperintense on both T1W1 
(13.73%) and T2WI (11.76%) indicating subacute 
thrombus with loss of signal void.  In both sequences 
brain oedema was the next most common finding: 
Haemorrhagic infarcts were observed in 7.84% of 
scans on T1W1 and T2WI images.
Figure 5
TOF MRV
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TOF MRV: As shown in Figure 5, the most commonly affected sites on MRV were SSS followed by the left 
TS. These two sites showed changes in 17 (33.3%) and 11 (21.6%) patients, respectively. The other sinus 
sites with changes in a significant number of patients were the right internal cerebral vein (9.8%, n = 5), left 
sigmoid sinus (7.8%, n = 4) and SS (7.8%, n = 4).
Representative images are shown below;
  
Illustration 1: 34 year old female with  seizures and h/o oral contraceptive use. Empty delta sign in the 
SSS and non non-enhancement of the sinus are seen. Bilateral parietal parenchymal changes are seen with 
haemorrhagic transformation on the right.
  
Illustration 2: A 33 year old female who presented with h/o severe headache. Axial NECT shows dense cord 
sign in the superficial cortical veins . CECT shows non-enhancement of the posterior SSS.
   
    A      B
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C
Illustration 3: A 33 year old female with h/o headache . There is loss of the signal void in the SSS (A and B). 
MRV done showed non-visualisation of the SSS and the right TS.
    
Illustration 4: 18 year old girl on treatment for DVT, who presented with seizures and syncope. NECT (A, 
B and C) shows ‘dense cord sign’ , left parietal parenchymalhaemorrhage and brain oedema. CECT (D) 
shows empty delta sign.
DISCUSSION
Cerebral venous sinus thrombosis affects all age 
groups but is most common in young adults and 
especially females. In this study females were more 
commonly affected than males especially in the 
age range 17-39 years. This correlates well with 
studies done elsewhere that have shown female 
preponderance (1, 2).The male patients seen did 
not show a particular age predominance indicating 
similar risk across the age groups.
 The most common presenting complaint of 
CVST in this study was headache. This correlates 
well with other studies done elsewhere which have 
shown headache as the most common presenting 
complaint (3, 4, and 9).  One patient presented with 
thunder clap headache and was initially worked up as 
a case of subarachnoid haemorrhage and was actually 
booked for four vessel angiogram. This was however 
obviated when CVST was diagnosed on CECT. This 
corresponds to   other studies which have shown that 
thunderclap headache occasionally occurs in CVST 
(2, 3). This entity can therefore be considered in the 
differential diagnosis of patients being evaluated for 
subarachnoid haemorrhage. 
 Other presenting complaints in order of 
frequency include; seizures, visual disturbance, 
neck pains and vomiting. The common examination 
findings documented include hemiplegia, focal 
neurological deficits, hemiparesis and altered 
consciousness. This correlates well with what has 
been seen in other studies (1, 2).
The most common aetiological factor seen was 
infection. This is at variance with other large studies 
by Ferro et al from Europe and South America and 
Wasay et al from US which have shown thrombophilia 
as the commonest cause. It however correlates well 
with a large study by Khealani in Pakistan and 
Middle East that showed infection as the commonest 
cause (5).This indicates a higher infective etiology in 
developing countries.
 Among the patients whose HIV status was 
known presence of HIV was associated with a higher 
likelihood of having co- morbid conditions especially 
infection . This then may increase the risk of CVST 
in HIV positive patients.
 The most common NECT finding was hyperdense 
sinus and cord sign. Parenchymal changes and brain 
oedema were seen in more than 50% of cases. This 
agrees with other studies that showed venous infarct 
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in over 50% of cases. It is however now agreed that 
parenchymal changes are not purely venous infarction 
but a combination of vasogenic oedema, cytotoxic 
oedema and infarction. Haemorrhagic parenchymal 
changes were seen in six cases.
 CECT findings included empty delta sign in 16 
cases followed by non enhancing sinus in three cases. 
Thus the empty delta sign was seen in 31% of cases. 
This agrees with most studies which have shown 
delta sign in 33% (5, 14, and 21). 
 The commonest finding on MRI was hyperintense 
thrombus with loss of signal void. This indicates most 
of these cases were seen in the subacutestage.TOF 
MRV showed filling defects in the sinuses.
 No CT venographic imaging study was 
documented. This is likely due to lack of awareness 
on the utility of this modality for evaluation of CVST. 
This article will help raise awareness on this modality 
as it is cheaper and more readily available than MRI 
and has comparable diagnostic quality.
 Although this study cannot claim to have 
discovered all cases of sinus thrombosis due to the 
sometimes non-specific presentation which may not 
have resulted in imaging and hence the diagnosis, 
we do not think this group was large enough to bias 
our results. A prospective study would answer some 
of our unanswered questions. Retrospective data has 
major flaws but we excluded as many patients with 
incomplete data as possible.
 The most commonly affected sinus on both CT 
and MRI/MRV was the SSS. This was followed by the 
transverse sinuses. The sigmoid and straight sinuses 
and internal cerebral and Great cerebral vein of Galen 
were less commonly involved. This correlates well 
with studies done by Ameri and Ferro et al. No case 
of cavernous or inferior sagittal sinus thrombosis was 
documented in this study.
CONCLUSION
CVST is most commonly seen in young adult females 
due to infection, pregnancy, puerperium and oral 
contraceptive use. The most common clinical finding 
in patients with CVST is headache. This is followed 
by seizures, neck pain, neurological deficits and 
visual disturbance. These clinical features are non-
specific therefore we need to maintain a high index 
of suspicion.
 Infective cause is much more common in our 
population compared to other regions. Thus CVST 
should specifically be sought in patients with CNS 
imaging studies in the right clinical setting.
 CVST is well demonstrated on neuroimanging 
studies of NECT, CECT, CTV and MRI/MRV therefore 
radiologists should maintain a high index of suspicion 
for dural sinus thromobosis especially for young 
adult females with headache and other non-specific 
clinical presentations.
 CT venography should also be considered for 
imaging patients with CVST as it is cheaper than MRI 
and has comparable diagnostic quality.
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